Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Frassoni

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Experimental Hematology|June 27, 2006
Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantationSara Pozzi, Daniela Lisini, Marina Podestà, et al.
Oncotarget|June 15, 2018
<i>CHL1</i> gene acts as a tumor suppressor in human neuroblastomaMarzia Ognibene, Gabriella Pagnan, Danilo Marimpietri, et al.
Cancer Medicine|May 12, 2016
The Wilms' tumor (WT1) gene expression correlates with the International Prognostic Scoring System (IPSS) score in patients with myelofibrosis and it is a marker of response to therapyDaniela Gallo, Paolo Nicoli, Chiara Calabrese, et al.
Blood|April 17, 2010
Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemiaSebastian Giebel, Myriam Labopin, Gerhard Ehninger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2003
Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationOlle Ringdén, Myriam Labopin, Norbert-Claude Gorin, et al.
Cell Transplantation|February 3, 2009
Mesenchymal stem cells protective effect in adriamycin model of nephropathyAlberto Magnasco, Mirko Corselli, Roberta Bertelli, et al.
BMC Immunology|October 4, 2014
Mesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantationMarilena Gregorini, Francesca Bosio, Chiara Rocca, et al.
Blood|April 12, 2003
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donorsSebastian Giebel, Franco Locatelli, Teresa Lamparelli, et al.
Blood|October 24, 2002
Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantationAlida Dominietto, Teresa Lamparelli, Anna Maria Raiola, et al.
Radiology|March 6, 2014
Adult advanced chronic lymphocytic leukemia: computational analysis of whole-body CT documents a bone structure alterationFrancesco Fiz, Cecilia Marini, Roberta Piva, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Experimental Hematology|June 27, 2006
Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantationSara Pozzi, Daniela Lisini, Marina Podestà, et al.
Oncotarget|June 15, 2018
<i>CHL1</i> gene acts as a tumor suppressor in human neuroblastomaMarzia Ognibene, Gabriella Pagnan, Danilo Marimpietri, et al.
Cancer Medicine|May 12, 2016
The Wilms' tumor (WT1) gene expression correlates with the International Prognostic Scoring System (IPSS) score in patients with myelofibrosis and it is a marker of response to therapyDaniela Gallo, Paolo Nicoli, Chiara Calabrese, et al.
Blood|April 17, 2010
Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemiaSebastian Giebel, Myriam Labopin, Gerhard Ehninger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2003
Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationOlle Ringdén, Myriam Labopin, Norbert-Claude Gorin, et al.
Cell Transplantation|February 3, 2009
Mesenchymal stem cells protective effect in adriamycin model of nephropathyAlberto Magnasco, Mirko Corselli, Roberta Bertelli, et al.
BMC Immunology|October 4, 2014
Mesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantationMarilena Gregorini, Francesca Bosio, Chiara Rocca, et al.
Blood|April 12, 2003
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donorsSebastian Giebel, Franco Locatelli, Teresa Lamparelli, et al.
Blood|October 24, 2002
Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantationAlida Dominietto, Teresa Lamparelli, Anna Maria Raiola, et al.
Radiology|March 6, 2014
Adult advanced chronic lymphocytic leukemia: computational analysis of whole-body CT documents a bone structure alterationFrancesco Fiz, Cecilia Marini, Roberta Piva, et al.
Pageof 11